Breast Cancer Patients Await Approval of Avastin

Patients suffering from breast cancer have been making a case for the Foods and Drugs Administration to approve Avastin as a prescribed medication for treating the illness. These presentations were made on the first day of the two-day hearing under progress. Genetech, which manufactures Avastin, is working to convince the FDA to reverse its December Read more